antiviral

Hosts: Vincent Racaniello, Alan Dove, Rich Condit, and Kathy Spindler The TWiV team reviews a meta-analysis of clinical trial reports on using Tamiflu for influenza, and suggestions on how to rescue US biomedical research from its systemic flaws. Click arrow to play Download TWiV 282 (75 MB .mp3, 104 min) Subscribe (free): iTunes, RSS, email Links for this episode World Malaria Day Review of oseltamivir clinical […]

{ 3 comments }

Host: Vincent Racaniello Guests: Susan Baker and Thomas Gallagher Vincent meets up with Susan Baker and Tom Gallagher at Loyola University to talk about their work on coronaviruses. Click arrow to play Download TWiV 276 (51 MB .mp3, 70 min) Subscribe (free): iTunes, RSS, email Links for this episode Papain-like viral proteases (Virus Res) MERS-CoV papain-like protease (Virology) Mouse model for […]

{ 0 comments }

TWiV 270: Homeland virology

February 2, 2014

Hosts: Vincent Racaniello and Rich Condit Guests: Dennis Hruby and Yoshihiro Kawaoka Vincent and Rich discuss avian influenza virus and an antiviral drug against smallpox with Dennis and Yoshi at the ASM Biodefense and Emerging Diseases Research Meeting in Washington, DC. Click arrow to play Download TWiV 270 (61 MB .mp3, 84 min) Subscribe (free): iTunes, RSS, email Links for this episode ASM Biodefense […]

{ 3 comments }

Hosts: Vincent Racaniello, Dickson Despommier, Alan Dove, Rich Condit, and Kathy Spindler In this second consecutive all-email episode, the complete TWiV team reads questions and comments from listeners about systemic antiviral responses, wild type poliovirus in Israel, Turkish scientists, viral symbiotes, and much more. Click arrow to play Download TWiV 253 (101 MB .mp3, 122 min) […]

{ 1 comment }

Hosts: Vincent Racaniello and Rich Condit Guests: Dave Evans, Stan Lemon, and Lorne Tyrrell Vincent and Rich recorded this episode before an audience at the 2nd Li Ka Shing Institute of Virology Symposium at the University of Alberta, where they spoke with Dave, Stan, and Lorne about their work on poxvirus vaccines and recombination, an enveloped picornavirus, […]

{ 1 comment }

TWiV 146: Draco’s potion

August 28, 2011

Hosts: Vincent Racaniello, Rich Condit, and Abbie Smith Vincent, Rich, and Abbie review a broad spectrum antiviral protein, and selective pressure applied by a failed HIV-1 vaccine. Click the arrow above to play, or right-click to download TWiV 146 (78 MB .mp3, 107 minutes). Subscribe to TWiV (free) in iTunes , at the Zune Marketplace, by […]

{ 6 comments }

Hosts: Vincent Racaniello, Alan Dove, and Rich Condit Vincent, Alan, and Rich discuss growth in culture of newly identified rhinovirus C, vaccinia transmission among wrestlers and martial artists, and results of phase III clinical trial of boceprevir, a new inhibitor of hepatitis C virus replication. Click the arrow above to play, or right-click to download TWiV #130 […]

{ 1 comment }

TWiV 121: Huskies go viral

February 20, 2011

Hosts: Vincent Racaniello, Michael Katze, Michael Gale, Deborah Fuller, and Shawn Iadonato A conversation about careers in virology, systems biology, innate immunity, and antiviral research recorded at the University of Washington in Seattle. Click the arrow above to play, or right click to download TWiV #121 (65 MB .mp3, 90 minutes). Subscribe to TWiV (free) in […]

{ 2 comments }

TWiV 99: ICAAC Boston 2010

September 19, 2010

Host: Vincent Racaniello On episode 99 of the podcast This Week in Virology, Vincent tours the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Boston, speaking with exhibitors and visitors, including Professors Derek Smith, Michael Schmidt, Frederick Hayden, and Myra McClure. Many thanks to Chris Condayan and Ray Ortega of the American Society for […]

{ 12 comments }

Hosts: Vincent Racaniello, Rich Condit, Karla Kirkegaard, and Marilyn Roosinck Vincent, Rich, Karla, and Marilyn recorded TWiV at the 29th Annual Meeting of the American Society for Virology in Bozeman, where they discussed plant viruses and how they make plants resistant to adverse conditions, and identification of dominant negative drug targets. Click the arrow above […]

{ 1 comment }